Initiatives and programs
We're working on a range of policy initiatives, programs and campaigns to help improve your health and the health of all Australians.
End of Life Essentials provides online education, a toolkit and web-based resources for clinicians working in acute settings.
This project helps clinicians learn about end-of-life law and the effects this has on end-of-life care and palliative care for patients.
This funded website provides current, authoritative and evidence-based information about fetal alcohol spectrum disorders (FASD). It has resources for parents and carers, researchers, health professionals and health care providers.
The Australian Government has established a program to support researchers to push the boundaries to develop new health and medical breakthroughs.
The Genomics Health Futures Mission will invest $500 million over 10 years in genomic research. It will improve testing and diagnosis for many diseases, help personalise treatment options to better target and improve health outcomes, and reduce unnecessary interventions and health costs.
The Global Health initiative will invest $28.4 million over 10 years to fund projects that improve our understanding of global health threats and how best to tackle them. The initial focus is on tackling antimicrobial resistance and drug-resistant tuberculosis.
The department is undertaking a review to advise and recommend possible enhancements to the Australian Men’s Shed Association’s (AMSA) governance arrangements and Australian Government funding to the men’s shed movement in Australia.
The Greater Choice for At Home Palliative Care measure aims to improve palliative care coordination through Primary Health Networks (PHNs).
Haemopoietic progenitor cells (HPC) therapy can save the lives of patients with conditions of the blood, blood-producing organs or immune system. The program funds several initiatives to help eligible Australians to access HPC treatments.
The Australian Government subsidises organisations to provide home care services to eligible older people. As an approved provider of Home Care Packages, make sure you understand how funding works, the fees you can charge, and what your responsibilities are.
The Immunoglobulin Review (Ig Review) Pilot Process is looking at the use of government-funded immunoglobulin treatment for selected conditions. This helps us make sure patients receive the most beneficial treatment available.
This project aims to improve access to palliative care for people with intellectual disability through a web-based toolkit and national data collection.
The Inborn Errors of Metabolism (IEM) program helps people and families who have problems with breaking down protein in their food. They need a special diet, and the IEM program helps them pay for their specialised food.
The Indigenous Health Research Fund (IHRF) is investing in Indigenous-led research to tackle health issues facing Aboriginal and Torres Strait Islander people.
Residential aged care facilities must appoint a clinical staff member as an infection prevention and control (IPC) lead. This ensures they are better prepared to prevent and respond to infectious diseases, including COVID-19 and influenza.
This program supports flexible ways of providing care where mainstream services cannot meet needs. It currently funds 8 innovative projects that focus on younger people with disabilities. The program stopped funding new projects in 2006.
The Australian Government is investing in a multi-year Intergenerational Health and Mental Health Study (IHMHS). The IHMHS will provide the most complete picture ever collected of Australia's physical and mental health.
The International Clinical Trial Collaboration (ICTC) initiative has been consolidated into the Clinical Trials Activity initiative under the MRFF 10-year plan. ICTC supported Australian researchers to conduct clinical trial research in collaboration with international researchers.
Keeping Australians out of Hospital has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year plan. This initiative supported research into preventive health measures for chronic health conditions, to keep people out of hospital.
The Life Saving Drugs Program (LSDP) pays for specific essential medicines to treat patients with rare and life-threatening diseases.
Lifting Clinical Trials and Registries Capacity – Clinical Trials Networks initiative has been consolidated into a part of the Clinical Trials Activity initiative under the MRFF 10-year plan.
Maternal Health and First 2000 Days/Women’s Health has been consolidated into the Preventive and Public Health Research initiative under the MRFF 10-year plan.